Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New calculator aims to predict c-section risk and improve birth outcomes

NCT ID NCT06488092

Knowledge-focused Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether using a cesarean risk calculator during labor can lower the number of C-sections and reduce complications for mothers and newborns. Researchers will track 20,000 women giving birth at full term to see if the tool helps guide decisions. The goal is to improve safety and help patients and doctors make more informed choices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cesarean Risk Calculator (a tool that estimates a woman's chance of needing a C-section)
What this could lead to
If successful, this tool could help doctors and patients make more informed decisions about labor, potentially reducing unnecessary C-sections and improving safety.
What could go wrong
This is an observational study, not a controlled trial, so it can show patterns but not prove cause and effect. The tool's impact may vary across different hospitals and patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: All postpartum patients who were eligible for cesarean risk calculator utilization: * delivery of a full-term (greater than or equal to 37 weeks) singleton gestation after presenting * with intact membranes * undergoing an induction of labor from cervical dilation less than or equal to 2cm Exclusion Criteria: Postpartum patient who had a prior pregnancy resulting in Cesarean delivery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean delivery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean delivery

Contacts and locations

Locations

  • Akron General

    Akron, Ohio, 44307, United States

  • Chester County Hosptial

    West Chester, Pennsylvania, 19380, United States

  • E.W. Sparrow Hospital

    Lansing, Michigan, 48912, United States

  • Fairview Hospital

    Cleveland, Ohio, 44111, United States

  • Henry Ford Hospital

    Detroit, Michigan, 48202, United States

  • Henry Ford Macomb Hospital

    Clinton Township, Michigan, 48038, United States

  • Hillcrest Hospital

    Mayfield Heights, Ohio, 44124, United States

  • Lancaster General Health

    Lancaster, Pennsylvania, 17602, United States

  • Logan Regional Hospital-Intermountain Healthcare

    Logan, Utah, 84341, United States

  • McKay-Dee Hospital

    Ogden, Utah, 84403, United States

  • Princeton Medical Center

    Plainsboro, New Jersey, 08536, United States

  • Riverton Hospital-Intermountain Healthcare

    Riverton, Utah, 84065, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • University of Utah Hospital

    Salt Lake City, Utah, 84132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.